Abstract
In recent decades the interest in intranasal drug administration is increased, not only for the treatment of acute and chronic diseases of the nasal cavity but mainly for drug delivery to the brain. The advantages of intranasal drug delivery (IDD) are the high bioavailability of drugs, rapid development of therapeutic effects, non-invasiveness, painlessness, and simple and comfortable application. In order to reach a high extent and rate of drug absorption and bioavailability, various approaches have been suggested, including application of micro- and nanocarriers. Intranasal administration is used for a wide variety of drugs, including proteins, peptides, and highly polar compounds. The opportunity to use IDD to the brain opens new promise for the effective treatment of cerebral pathologies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
